BROOKS LABORATORIES : PARTIALLY MONETIZES INVESTMENT IN BROOKS STERISCIENCE LIMITED FOR RS 106.33 CR

• Board of Directors approved sale of 51,220 Equity Shares held in Brooks Steriscience Limited to Steriscience Specialties Private Limited. • Transaction approved on June 19, 2026. • Cash consideration of ₹20,760 per share, aggregating to approximately ₹106.33 crore. • This represents a partial monetization and not a complete divestment. • Post-transaction, Brooks Laboratories will hold 1,02,440 Equity Shares, representing 32.67% of the paid-up share capital. • The proceeds will be deployed towards company's growth strategy, including expansion of operations and capacity enhancement.

Brooks Laboratories Limited

Open attachment

← Back to feed